News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Older Drug Better Than New For Blood Cell Disorder


10/19/2005 5:09:28 PM

The older generic drug hydroxyurea, if combined with a small dose of aspirin and given to people with thrombocythemia, is more effective in preventing serious bleeding and other complications than the newer and more expensive Agrylin, according to a study. Agrylin, also known as anagrelide, is made by Roberts Pharmaceuticals, which merged with Shire Pharmaceuticals Group in 1999.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES